芪苈强心胶囊对急性心肌梗死行延迟性PCI术后心力衰竭患者的治疗作用  

Therapeutic Effect of Qiliqiangxin Capsule Treating Heart Failure after Delayed PCI for Acute Myocardial Infarction

作　　者：白玲强[1] 于军[1] 姜敏华[1] 陈万强[1] 杨瑞金[1] 李永慧[1] 

机构地区：[1]中国人民解放军第三医院,宝鸡721003

出　　处：《世界中医药》2013年第6期686-688,共3页World Chinese Medicine

摘　　要：目的:观察芪苈强心胶囊在AMI患者延迟性PCI术后心力衰竭(HF)的疗效。方法:将40例AMI后行延迟性PCI术治疗后出现HF患者随机分为2组,对照组20例给予标准抗HF治疗,治疗组20例在对照组治疗基础上加服芪苈强心胶囊。2组治疗3个月后观察临床疗效和超声心动图左室射血分数(LVEF)变化。结果:总有效率治疗组与对照组比较差异有统计学意义(P<0.05),治疗组6min步行实验及左室射血分数(LVEF)明显高于对照组,差异有统计学意义(P<0.05)。结论:芪苈强心胶囊联合常规西药治疗对急性心肌梗死延迟性PCI术后心力衰竭患者的心功能改善有一定疗效。Objective：To observe the therapeutic effect of Qiliqiangxin capsule treating heart failure（HF） after delayed PCI for acute myocardial infarction.Methods：Forty patients who had heart failure after delayed PCI for acute myocardial infarction were randomly divided into two groups.The 20 patients in the control group were given standard anti-HF treatment,and the other 20 patients in the treatment group received extra administration of qiliqiangxin capsule.Clinical therapeutic effect and LVEF were observed after three months of treatment.Results：The total effective rates showed statistically significant differences between the two groups（P ＆lt; 0.05）.The walking test results in 6 minutes and LVEF in treatment group were significantly higher than that of the control group（P ＆lt; 0.05）.Conclusion：Qiliqiangxin capsule treating heart failure（HF） after delayed PCI for acute myocardial infarction shows certain therapeutic effect in improving heart function.

关 键 词：急性心肌梗死(AMI) 心力衰竭(HF) 延迟性PCI 芪苈强心胶囊 

分 类 号：R541[医药卫生—心血管疾病]